Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMhp Reg S Regulatory News (MHPC)

Share Price Information for Mhp Reg S (MHPC)

Share Price is delayed by 15 minutes
Get Live Data
9.30    0.48 (5.44%)
Bid:
9.06
Ask:
9.30
Spread: 0.24 (2.649%)
Market Cap: $995.46m
MHPC Live PriceLast checked at - London Stock Exchange

Intraday Mhp Reg S Share Chart

  • This share is an international stock.

MHP Tap Pricing Announcement

4 Feb 2026 07:00

RNS Number : 6762R
MHP SE
04 February 2026
 

 

3 February 2026

MHP SE TAP OFFERING PRICING ANNOUNCEMENT

MHP SE, the parent company of a leading international food and agricultural group with Ukrainian roots and one of the largest poultry producers in Europe, has announced that it has priced its additional U.S.$100 million aggregate principal amount of 10.500% notes due 2029 (the "Additional Notes") of its wholly owned subsidiary, MHP Lux S.A., a company incorporated in Luxembourg (together with MHP SE and its consolidated subsidiaries, the "Group") to be consolidated and form a single series with the U.S.$450 million aggregate principal amount of 10.500% notes due 2029 issued by MHP Lux S.A. on 28 January 2026 (the "Original Notes" and together with the Additional Notes, the "Notes"). The Additional Notes will be issued at an issue price of 104.000%, plus accrued interest from January 28, 2026 up to, but excluding, the issue date of the Additional Notes.

The Group intends to use the proceeds of the Additional Notes, along with the proceeds of the Original Notes, to fund the tender offer and redemption of the entire U.S.$550 million outstanding aggregate principal amount of MHP Lux S.A.'s 6.95% Notes due 2026 (the "2026 Notes"). The Offering replaces the use of U.S.$100 million of the Group's internal cash that was originally earmarked for partial repayment of the 2026 Notes. The retained cash, including any proceeds in excess of U.S.$100 million, will instead be primarily kept outside of Ukraine and allocated to the Group's future investment initiatives, including capital expenditures and ongoing operational needs.

 

Disclaimer

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy securities to any person in the United States or in any jurisdiction to whom or in which such offer or solicitation is unlawful, and persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions. The securities referred to herein may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended (the "Securities Act"), or another exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Subject to certain exceptions, the securities referred to herein may not be offered or sold in Australia, Canada or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada or Japan. The offer and sale of the securities referred to herein has not been and will not be registered under the Securities Act or under the applicable securities laws of Australia, Canada or Japan. There will be no public offer of the securities in the United States.

This announcement is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the Order) or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as relevant persons). The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this announcement or any of its contents.

This announcement is not an advertisement of securities in Ukraine, and is not an offer or invitation to, or solicitation of, any such circulation, distribution, placement, sale, purchase or other transfer of the securities in the territory of Ukraine. It is not intended to be and must not be publicly distributed in or into Ukraine.

This announcement, or any other documents or materials relating to the Offering, as well as any disclosure statements or information therein relating to the Offering will not be released, issued, published, communicated, advertised or disseminated to the public in Cyprus.

This announcement and all other documents and materials relating to the Offering do not constitute investment advice or a recommendation under Cyprus law, nor do they constitute an offer or advertisement of securities in Cyprus, they are not intended to be and must not be distributed via information distribution channels or to the public in Cyprus.

Neither this announcement nor any other documents or materials relating to the Offering (whether in its preliminary or final form) has been registered or is intended to be registered and has not been submitted or is intended to be submitted for approval to the Cyprus Securities and Exchange Commission ("CySEC").

This announcement and any other documents and materials relating to the Offering may be distributed in Cyprus by a duly licensed investment firm or by a credit institution authorized under Directive 2013/36/EU or by a third-country firm providing investment services or performing investment activities through the establishment of a branch in Cyprus (collectively, the "Authorised Intermediaries"), permitted and authorised to provide investment services and conduct investment activities in Cyprus in accordance with the following enactments:

 

(a) the Investment Services and Activities and Regulated Markets Law, No. 144 (I) of 2007, as amended from time to time (the "2007 Investment Services Law");

(b) the Investment Services and Activities and Regulated Markets Law, No. 87(I)/2017, as amended from time to time (the "2017 Investment Services Law");

(c) Regulation (EU) No. 600/2014 of the European Parliament and of the Council of May 15, 2014 on markets in financial instruments and amending Regulation (EU) No. 648/2012, as amended from time to time ("MiFIR"),

and only to professional clients in Cyprus as defined in the 2007 Investment Services Law and in the 2017 Investment Services Law.

This announcement and any other documents and materials relating to the Offering may not be used for any invitation or solicitation purposes for or in connection with the sale, marketing, offering or acquisition of any securities in Cyprus in circumstances under which it is unlawful under Cyprus laws to make such an invitation or solicitation.

Please address any questions or concerns to:Anastasiia Sobotiuk (Kyiv)

IR Director, ESG Compliance and Reporting +38 050 339 29 99

a.sobotyuk@mhp.com.ua

Christakis Taoushanis (Cyprus)

Senior Independent Director +357 99 35 22 22

t.taoushanis@mhp.com.cy

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFVRFIISIIR
Date   Source Headline
4th Nov 20219:54 amRNSDate Notification
20th Oct 20218:41 amRNSPre-close trading update for Q3 and 9M 2021
9th Sep 20217:32 amRNSFinancial Results for H1 and Q2 2021 (2 part)
9th Sep 20217:32 amRNSFinancial Results for H1 and Q2 2021
23rd Aug 202110:30 amRNSDate notification
16th Jul 20219:15 amRNSPre-Close TU for the Q2 and 6M 2021
30th Jun 202111:03 amRNSMHP today releases Non-Financial Report 2020
19th May 20217:03 amRNSFinancial Results for the Q1 2021
11th May 202111:46 amRNSDate Notification
28th Apr 202112:02 pmRNSDistribution of Dividends
28th Apr 202111:44 amRNSMinutes of 2021 AGM
21st Apr 202112:40 pmRNSMerger of MHP SE with Raftan, Hemiak and Eledem
16th Apr 20219:20 amRNSPre-close TU for the Q1 2021 corrected version
15th Apr 20217:03 amRNSPre-close trading update for the Q1 2021
29th Mar 20219:54 amRNSAGM Date Change Notification
24th Mar 202111:37 amRNSFinancial results for the Q4 and 12M 2020
24th Mar 20218:35 amRNSSeparate Financial Statements
24th Mar 20218:11 amRNSAnnual Report 2020 Full version
24th Mar 20217:00 amRNSFinancial results for the Q4 and 12M 2020
18th Mar 20212:41 pmRNSMerger of MHP SE with Raftan, Hemiak and Eledem
15th Mar 20217:28 amRNSDate Notification
15th Feb 20211:08 pmRNSNotice of Extraordinary General Meeting
15th Feb 202111:42 amRNSMerger of MHP SE
9th Feb 20212:33 pmRNSRetirement of director
28th Jan 20217:00 amRNSPre-close trading update for the Q4 and 12M 2020
19th Jan 20212:06 pmRNSBoard Changes
23rd Nov 20204:40 pmRNSSecond Price Monitoring Extn
23rd Nov 20204:35 pmRNSPrice Monitoring Extension
18th Nov 20207:00 amRNSFinancial Results for the Q3 and 9M 2020
13th Nov 20207:07 amRNSDate Notification
21st Oct 20207:09 amRNSPre-close TU for the Q3 and 9M 2020
4th Sep 20207:00 amRNSQ2 and H1 2020 Financial Results
26th Aug 20209:28 amRNSQ1 and H1 2020 Date Notification
24th Aug 202012:08 pmRNSSecond Price Monitoring Extn
24th Aug 202012:03 pmRNSPrice Monitoring Extension
20th Aug 20204:41 pmRNSSecond Price Monitoring Extn
20th Aug 20204:35 pmRNSPrice Monitoring Extension
27th Jul 20207:22 amRNSPre-Close TU for the Q2 and six months 2020
2nd Jul 20204:35 pmRNSPrice Monitoring Extension
30th Jun 20202:12 pmRNSNon-Financial Report 2019
18th Jun 20201:17 pmRNSResults of AGM
2nd Jun 20207:08 amRNS1st Quarter Results
26th May 20207:00 amRNSDate Notification
15th May 20208:10 amRNSNotice of Annual General Meeting
14th May 20203:28 pmRNSNotification about threshold crossing in MHP’sGDRs
23rd Apr 20207:02 amRNSPre-close trading update for the Q1 2020
16th Apr 20207:00 amRNSDistribution of Dividends
14th Apr 202010:49 amRNSAnnual Financial Report 2019
14th Apr 20208:58 amRNSMHP SE Standalone Financial Statements 2019
14th Apr 20207:07 amRNSMHP SE Financial Statements 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.